LORI DAVILA: Open Payments
NPI 1306222328 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,080 in 112 payments from 18 companies in 2025. Trend: 2023 $2,730 · 2024 $2,210 · 2025 $3,080
Food & beverage: $3,046Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $672 |
| GENZYME CORPORATION | 12 | $576 |
| GlaxoSmithKline, LLC. | 18 | $403 |
| Genentech USA, Inc. | 11 | $336 |
| Novartis Pharmaceuticals Corporation | 13 | $263 |
| CSL Behring | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| LEO Pharma Inc. | 1 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Galderma Laboratories, L.P. | 3 | $52 |
Products named: DUPIXENT, Xolair, NUCALA, TEZSPIRE, FASENRA, Andembry, Rhapsido, ANZUPGO.
Industry payments across FL — which companies pay providers there.
